| No Intraepithelial Lesion | Squamous Intraepithelial Lesion |  | |||
---|---|---|---|---|---|---|
Total (n = 396) | Total (n = 75) | LSIL (n = 31) | HSIL (n = 44) | p OR [95% CI] | p’ OR [95% CI] | |
HPV positive women | 97 | 63 | 27 | 36 | Â | Â |
HPV prevalence (%) | 24.5 | 84 | 87.1 | 81.8 | 0.541 | <10-6 |
1.5 [0.409–5.503] | 16.183 [8.377–31.262] | |||||
HR-HPV positive women | 55 | 39 | 11 | 28 | Â | Â |
HR-HPV prevalence (%) | 14.9 | 59.1 | 42.3 | 70 | 0.025 | <10-6 |
3.181[1.135–8.920] | 8.273 [4.687–14.602] |